Skip to content

Cambridge Investment Research Advisors, Inc.: GOLY position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Cambridge Investment Research Advisors, Inc. on GOLY, newest first. How the timeline and the estimate are built.

Cambridge Investment Research Advisors, Inc. held 79,373 GOLY shares at 2026-06-30 per its 13F-HR/A filed 2026-07-30.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F/A 79,373 shares
    Change vs previous 13F -34,710 shares

    <0.01% of the 13F portfolio, value $1,996,000.

    13F-HR/A 0001419186-26-000006 filed by Cambridge Investment Research Advisors, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 114,083 shares
    Change vs previous 13F +19,718 shares

    0.01% of the 13F portfolio, value $3,360,000.

    13F-HR 0001419186-26-000003 filed by Cambridge Investment Research Advisors, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 94,365 shares
    Change vs previous 13F +3,742 shares

    0.01% of the 13F portfolio, value $3,298,000.

    13F-HR 0001419186-26-000001 filed by Cambridge Investment Research Advisors, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 90,623 shares
    Change vs previous 13F +12,931 shares

    0.01% of the 13F portfolio, value $2,992,000.

    13F-HR 0001419186-25-000008 filed by Cambridge Investment Research Advisors, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 77,692 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $2,279,000.

    13F-HR 0001419186-25-000006 filed by Cambridge Investment Research Advisors, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).